From left) Dr. Amal Makhloufi, Country Lead for Sanofi Philippines, General Manager for Sanofi General Medicines, H.E. Michèle Boccoz, Ambassador of France to the Philippines, Fernando Zobel de Ayala, president and chief operating officer, Ayala Corporation and Paolo Maximo Borromeo, President and CEO, AC Health
IN the wake of a global pandemic, Sanofi identifies one of the main problems in Philippine healthcare to be the disruption of treatment in lifestyle disease patients, specifically for diabetes and hypertension.